ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression

Clinical trial NCT05434156 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05434156
Sponsor: Eleusis Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Major Depressive Disorder Depression

Start date: 2022-10-27
Primary completion: 2025-12-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.